Therefore, our results suggest that the bioactive constituent of Aloe perryi extracts could serve as a targeted therapy for estrogen receptor α positive breast cancer or androgen receptor prostate cancer, which warrant further research and investigations [46]. The gene discussed is AR; the disease is prostate carcinoma.